Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PARATEK PHARMACEUTICALS via PARATEK PHARMACEUTICALS
2026 · third_quarter · Q3
FY 27 DOD Appropriations FY 27 HHS Appropriations FY 27 VA Report Language Biodefense Funding
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
PARATEK PHARMACEUTICALS via PARATEK PHARMACEUTICALS
2026 · second_quarter · Q2
Source: Senate LDA
FY 27 DOD Appropriations FY 27 HHS Appropriations FY 27 VA Report Language Biodefense Funding
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
PARATEK PHARMACEUTICALS via PARATEK PHARMACEUTICALS
2026 · first_quarter · Q1
FY 27 DOD Appropriations FY 27 HHS Appropriations Biodefense Funding
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
PARATEK PHARMACEUTICALS via PARATEK PHARMACEUTICALS
2025 · fourth_quarter · Q4
FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARATEK PHARMACEUTICALS via PARATEK PHARMACEUTICALS
2025 · third_quarter · Q3
FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARATEK PHARMACEUTICALS via PARATEK PHARMACEUTICALS
2025 · second_quarter · Q2
FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARATEK PHARMACEUTICALS via PARATEK PHARMACEUTICALS
2025 · first_quarter · Q1
FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARATEK PHARMACEUTICALS via PARATEK PHARMACEUTICALS
2025 · first_quarter · RR
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.